Have a personal or library account? Click to login
Is Lone Hypertension a Risk Factor for More Severe COVID-19 Outcomes? Cover

Is Lone Hypertension a Risk Factor for More Severe COVID-19 Outcomes?

Open Access
|Mar 2022

References

  1. 1Whelton PK, Williams B. The 2018 European society of cardiology/European society of hypertension and 2017 American college of cardiology/American heart association blood pressure guidelines: More similar than different. J Am Med Assoc. 2018; 320: 174950. DOI: 10.1001/jama.2018.16755
  2. 2Garg S, Kim L, Whitaker M, et al. Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019 — COVID-NET, 14 states, March 1–30, 2020. MMWR Morb Mortal Wkly Rep. 2020; 69: 45864. DOI: 10.15585/mmwr.mm6915e3
  3. 3CDC. Certain medical conditions and risk for severe COVID-19 illness. https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html (accessed 10 March 10 2021).
  4. 4Kim L, Garg S, O’Halloran A, et al. Risk factors for intensive care unit admission and in-hospital mortality among hospitalized adults identified through the US coronavirus disease 2019 (COVID-19)-associated hospitalization surveillance network (COVID-NET). Clin Infect Dis. 2020; published online July 16. DOI: 10.1093/cid/ciaa1012
  5. 5Yuan N, Ji H, Sun N, et al. Pseudo-safety in a cohort of patients with COVID-19 discharged home from the emergency department. Emerg Med J. 2021; 14. DOI: 10.1136/emermed-2020-210041
  6. 6Huang Y, Lu Y, Huang YM, et al. Obesity in patients with COVID-19: A systematic review and meta-analysis. Metabolism. 2020; 113: 154378. DOI: 10.1016/j.metabol.2020.154378
  7. 7Kompaniyets L, Goodman AB, Belay B, et al. Body mass index and risk for COVID-19-related hospitalization, intensive care unit admission, invasive mechanical ventilation, and death—United States, March–December 2020. MMWR Morb Mortal Wkly Rep. 2021; 70. DOI: 10.15585/mmwr.mm7010e4
  8. 8Order of the President of the Republic of Uzbekistan. About formation of the special republican commission but preparation of the program of measures for the prevention…. https://cis-legislation.com/document.fwx?rgn=122506 (accessed 10 Feb 2021).
  9. 9UZ Daily. Interim clinical guideline for the management of patients with mild COVID-19 at home approved. https://www.uzdaily.uz/en/post/58415 (accessed 10 Feb 2021).
  10. 10Cosentino F, Grant PJ, Aboyans V, et al. 2019 ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J. 2020; 41: 255323.
  11. 11Neumann FJ, Sechtem U, Banning AP, et al. 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. Eur. Heart J. 2020; 41: 40777. DOI: 10.1093/eurheartj/ehz486
  12. 12Yumuk V, Tsigos C, Fried M, et al. European guidelines for obesity management in adults. Obes Facts. 2015; 8: 40224. DOI: 10.1159/000442721
  13. 13Bakris G, Ali W, Parati G. ACC/AHA versus ESC/ESH on hypertension guidelines: JACC guideline comparison. J. Am. Coll. Cardiol. 2019; 73: 301826. DOI: 10.1016/j.jacc.2019.03.507
  14. 14Williams B, Mancia G, Spiering W, et al. 2018 practice guidelines for the management of arterial hypertension of the European society of hypertension (ESH) and the European society of cardiology (ESC). Blood Press. 2018; 27: 31440. DOI: 10.1080/08037051.2018.1527177
  15. 15Zhu J, Ji P, Pang J, et al. Clinical characteristics of 3062 COVID-19 patients: A meta-analysis. J Med Virol. 2020; 92: 190214. DOI: 10.1002/jmv.25884
  16. 16Al-Tawfiq JA, Leonardi R, Fasoli G, Rigamonti D. Prevalence and fatality rates of COVID-19: What are the reasons for the wide variations worldwide? Travel Med. Infect. Dis. 2020; 35: 101711. DOI: 10.1016/j.tmaid.2020.101711
  17. 17Yang J, Zheng Y, Gou X, et al. Prevalence of comorbidities and its effects in coronavirus disease 2019 patients: A systematic review and meta-analysis. Int J Infect Dis. 2020; 94: 915. DOI: 10.1016/j.ijid.2020.03.017
  18. 18Bavishi C, Whelton PK, Mancia G, Corrao G, Messerli FH. Renin-angiotensin-system inhibitors and all-cause mortality in patients with coronavirus disease 2019: A systematic review and meta-analysis of observational studies. J Hypertens. 2021; published online Feb 3. DOI: 10.1097/HJH.0000000000002784
DOI: https://doi.org/10.5334/gh.1099 | Journal eISSN: 2211-8179
Language: English
Submitted on: Jan 7, 2022
Accepted on: Jan 26, 2022
Published on: Mar 1, 2022
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2022 Evgeniya V. Shalaeva, Alisher К. Shadmanov, Feruza L. Azizova, Khilola T. Mirakhmedova, Franz H. Messerli, Oscar H. Franco, Hugo Saner, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.